Flavonoids and metabolic syndrome

Annals of the New York Academy of Sciences

Volumn 1259, Issue 1, 2012, Pages 87-94

  Galleano, Monica ^a   Calabro, Valeria ^a   Prince, Paula D ^a   Litterio, María C ^a   Piotrkowski, Barbara ^a   Vazquez Prieto, Marcela A ^b   Miatello, Roberto M ^b   Oteiza, Patricia I ^c   Fraga, Cesar G ^a,c  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b UNIVERSIDAD NACIONAL DE CUYO   (Argentina)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Diabetes; Hypertension; Inflammation; Lipids; Obesity; Polyphenols

Indexed keywords

ADIPONECTIN; ADIPONECTIN RECEPTOR 1; ADIPONECTIN RECEPTOR 2; CATECHIN; DEGLYCYRRHIZINATED LIQUORICE; EPICATECHIN; EPICATECHIN GALLATE; EPIGALLOCATECHIN; EPIGALLOCATECHIN GALLATE; FLAVONOID; GALANGIN; GLUCOSE; HESPERIDIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; INDUCIBLE NITRIC OXIDE SYNTHASE; MITOGEN ACTIVATED PROTEIN KINASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROANTHOCYANIDIN; PROCYANIDIN; PROTEIN P47; QUERCETIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; RESISTIN; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; STEROL REGULATORY ELEMENT BINDING PROTEIN 2; TRANSCRIPTION FACTOR AP 1; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG;

APPLE JUICE; ARTICLE; BODY COMPOSITION; BODY WEIGHT; CACAO; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL SYNTHESIS; DIASTOLIC BLOOD PRESSURE; DIET SUPPLEMENTATION; DIETARY INTAKE; ENZYME ACTIVATION; FATTY ACID OXIDATION; GLUCOSE BLOOD LEVEL; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; IN VIVO STUDY; INFLAMMATION; INSULIN RESISTANCE; INTRAABDOMINAL FAT; LEAN BODY WEIGHT; LIPID METABOLISM; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PROTEIN EXPRESSION; RISK FACTOR; SIGNAL TRANSDUCTION; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; UPREGULATION; WAIST CIRCUMFERENCE; WEIGHT GAIN;

EID: 84863503236     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2012.06511.x     Document Type: Article

References (77)

1. Reavan, G.M. 1988. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37: 1595-1607.
2. Alberti, K.G. et al 2009. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120: 1640-1645.
3. Fogli-Cawley, J.J. et al 2007. The 2005 Dietary Guidelines for Americans and risk of the metabolic syndrome. Am. J. Clin. Nutr. 86: 1193-1201.
4. Kesse-Guyot, E. et al 2011. Adherence to French nutritional guidelines is associated with lower risk of metabolic syndrome. J. Nutr. 141: 1134-1139.
5. USDA. 2005. Dietary Guidelines for Americans. US Department of Agriculture and Department of Health and Human Services 6th ed. Washington, DC
6. Estaquio, C. et al 2008. The French National Nutrition and Health Program score is associated with nutritional status and risk of major chronic diseases. J. Nutr. 138: 946-953.
7. Manach, C. et al 2004. Polyphenols: food sources and bioavailability. Am. J. Clin. Nutr. 79: 727-747.
8. Scalbert, A. & G. Williamson 2000. Dietary intake and bioavailability of polyphenols. J. Nutr. 130: 2073S-2085S.
9. Jaganath, I.B. & A. Crozier 2010. Dietary flavonoids and phenolic compounds. In Plant Phenolics and Human Health: Biochemistry, Nutrition, and Pharmacology. C.G. Fraga, Ed.: 1-4. John Wiley & Sons. Hoboken, New Jersey
10. Frei, B. & J.V. Higdon 2003. Antioxidant activity of tea polyphenols in vivo: evidence from animal studies. J. Nutr. 133: 3275S-3284S.
11. Halliwell, B. et al 2005. Health promotion by flavonoids, tocopherols, tocotrienols, and other phenols: direct or indirect effects? Antioxidant or not? Am. J. Clin. Nutr. 81: 268S-276S.
12. Fraga, C.G. 2007. Plant polyphenols: how to translate their in vitro antioxidant actions to in vivo conditions. IUBMB Life 59: 308-315.
13. Holst, B. & G. Williamson 2008. Nutrients and phytochemicals: from bioavailability to bioefficacy beyond antioxidants. Curr. Opin. Biotechnol. 19: 73-82.
14. Fraga, C.G. et al 2010. Basic biochemical mechanisms behind the health benefits of polyphenols. Mol. Aspects Med. 31: 435-445.
15. Galleano, M. et al 2010. Antioxidant actions of flavonoids: thermodynamic and kinetic analysis. Arch. Biochem. Biophys. 501: 23-30.
16. Kopelman, P.G. 2000. Obesity as a medical problem. Nature 404: 635-643.
17. Despres, J.P. et al 2008. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler. Thromb. Vasc. Biol. 28: 1039-1049.
18. Ross, R. et al 2002. Abdominal obesity, muscle composition, and insulin resistance in premenopausal women. J. Clin. Endocrinol. Metab. 87: 5044-5051.
19. Barth, S.W. et al 2011. Moderate effects of apple juice consumption on obesity-related markers in obese men: impact of diet-gene interaction on body fat content. Eur. J. Nutr. [Epub ahead of print Oct 25]. doi:
20. Almoosawi, S. et al 2010. The effect of polyphenol-rich dark chocolate on fasting capillary whole blood glucose, total cholesterol, blood pressure and glucocorticoids in healthy overweight and obese subjects. Br. J. Nutr. 103: 842-850.
21. Bell, Z.W. et al 2011. A dual investigation of the effect of dietary supplementation with licorice flavonoid oil on anthropometric and biochemical markers of health and adiposity. Lipids Health Dis. 10: 29.
22. Knab, A.M. et al 2011. Quercetin with vitamin C and niacin does not affect body mass or composition. Appl. Physiol. Nutr. Metab. 36: 331-338.
23. Phung, O.J. et al 2010. Effect of green tea catechins with or without caffeine on anthropometric measures: a systematic review and meta-analysis. Am. J. Clin. Nutr. 91: 73-81.
24. Dulloo, A.G. et al 1999. Efficacy of a green tea extract rich in catechin polyphenols and caffeine in increasing 24-h energy expenditure and fat oxidation in humans. Am. J. Clin. Nutr. 70: 1040-1045.
25. Rains, T.M. et al 2011. Antiobesity effects of green tea catechins: a mechanistic review. J. Nutr. Biochem. 22: 1-7.
26. Kawaguchi, K. et al 1997. Hesperidin as an inhibitor of lipases from porcine pancreas and Pseudomonas. Biosci. Biotechnol. Biochem. 61: 102-104.
27. Sbarra, V. et al 2005. In vitro polyphenol effects on activity, expression and secretion of pancreatic bile salt-dependent lipase. Biochim. Biophys. Acta 1736: 67-76.
28. Babu, P.V. & D. Liu 2008. Green tea catechins and cardiovascular health: an update. Curr. Med. Chem. 15: 1840-1850.
29. Peng, C.H. et al 2011. Mulberry water extracts possess an anti-obesity effect and ability to inhibit hepatic lipogenesis and promote lipolysis. J. Agric. Food Chem. 59: 2663-2671.
30. Goto, T. et al 2011. Tiliroside, a glycosidic flavonoid, ameliorates obesity-induced metabolic disorders via activation of adiponectin signaling followed by enhancement of fatty acid oxidation in liver and skeletal muscle in obese-diabetic mice. J. Nutr. Biochem. [Epub ahead of print Sept 1].
31. Guzik, T.J. et al 2006. Adipocytokines-novel link between inflammation and vascular function? J. Physiol. Pharmacol. 57: 505-528.
32. Hotamisligil, G.S. et al 1993. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259: 87-91.
33. Fraga, C.G. & P.I. Oteiza 2011. Dietary flavonoids: role of (-)-epicatechin and related procyanidins in cell signaling. Free Radic. Biol. Med. 51: 813-823.
34. Vazquez-Prieto, M.A. et al 2011. Effect of red wine on adipocytokine expression and vascular alterations in fructose-fed rats. Am. J. Hypertens. 24: 234-240.
35. Rivera, L. et al 2008. Quercetin ameliorates metabolic syndrome and improves the inflammatory status in obese Zucker rats. Obesity (Silver Spring) 16: 2081-2087.
36. Bose, M. et al 2008. The major green tea polyphenol, (-)-epigallocatechin-3-gallate, inhibits obesity, metabolic syndrome, and fatty liver disease in high-fat-fed mice. J. Nutr. 138: 1677-1683.
37. Terra, X. et al 2011. Modulatory effect of grape-seed procyanidins on local and systemic inflammation in diet-induced obesity rats. J. Nutr. Biochem. 22: 380-387.
38. Sakurai, T. et al 2010. Oligomerized grape seed polyphenols attenuate inflammatory changes due to antioxidative properties in coculture of adipocytes and macrophages. J. Nutr. Biochem. 21: 47-54.
39. Overman, A. et al 2011. Quercetin attenuates inflammation in human macrophages and adipocytes exposed to macrophage-conditioned media. Int. J. Obes. 35: 1165-1172.
40. Liu, H.S. et al 2006. Inhibitory effect of green tea (-)-epigallocatechin gallate on resistin gene expression in 3T3-L1 adipocytes depends on the ERK pathway. Am. J. Physiol. Endocrinol. Metab. 290: E273-E281.
41. Vazquez-Prieto, M.A. et al. 2012. (-)-Epicatechin prevents TNFα-induced activation of signaling cascades involved in inflammation and insulin sensitivity in 3T3-L1 adipocytes. Arch. Biochem. Biophys. [Epub ahead of print March 8].
42. Imai, K. & K. Nakachi 1995. Cross sectional study of effects of drinking green tea on cardiovascular and liver diseases. Br. Med. J. 310: 693-696.
43. Basu, A. & T.J. Lyons 2011. Strawberries, blueberries, and cranberries in the metabolic syndrome: clinical perspectives. J. Agric. Food Chem. [Epub ahead of print Nov 29]. doi:
44. Nagao, T. et al 2009. A catechin-rich beverage improves obesity and blood glucose control in patients with type 2 diabetes. Obesity (Silver Spring) 17: 310-317.
45. Egert, S. et al 2010. Serum lipid and blood pressure responses to quercetin vary in overweight patients by apolipoprotein E genotype. J. Nutr. 140: 278-284.
46. Mulvihill, E.E. et al 2009. Naringenin prevents dyslipidemia, apolipoprotein B overproduction, and hyperinsulinemia in LDL receptor-null mice with diet-induced insulin resistance. Diabetes 58: 2198-2210.
47. Yokozawa, T. et al 2008. Gravinol ameliorates high-fructose-induced metabolic syndrome through regulation of lipid metabolism and proinflammatory state in rats. J. Agric. Food Chem. 56: 5026-5032.
48. Shabrova, E.V. et al 2011. Insights into the molecular mechanisms of the anti-atherogenic actions of flavonoids in normal and obese mice. PLoS One 6: e24634.
49. Mulvihill, E.E. et al 2010. Naringenin decreases progression of atherosclerosis by improving dyslipidemia in high-fat-fed low-density lipoprotein receptor-null mice. Arterioscler. Thromb. Vasc. Biol. 30: 742-748.
50. Huang, H.C. & J.K. Lin 2011. Pu-erh tea, green tea, and black tea suppresses hyperlipidemia, hyperleptinemia and fatty acid synthase through activating AMPK in rats fed a high-fructose diet. Food Funct. [Epub ahead of print Nov 30]. doi:
51. Horton, J.D. et al 2002. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J. Clin. Invest. 109: 1125-1131.
52. Del Bas, J.M. et al 2008. Dietary procyanidins lower triglyceride levels signaling through the nuclear receptor small heterodimer partner. Mol. Nutr. Food Res. 52: 1172-1181.
53. Del Bas, J.M. et al 2009. Dietary procyanidins enhance transcriptional activity of bile acid-activated FXR in vitro and reduce triglyceridemia in vivo in a FXR-dependent manner. Mol. Nutr. Food Res. 53: 805-814.
54. Quesada, H. et al 2009. Grape seed proanthocyanidins correct dyslipidemia associated with a high-fat diet in rats and repress genes controlling lipogenesis and VLDL assembling in liver. Int. J. Obes. 33: 1007-1012.
55. Baiges, I. et al 2010. Lipogenesis is decreased by grape seed proanthocyanidins according to liver proteomics of rats fed a high fat diet. Mol. Cell Proteomics 9: 1499-1513.
56. Honda, K. et al 2009. The molecular mechanism underlying the reduction in abdominal fat accumulation by licorice flavonoid oil in high fat diet-induced obese rats. Anim. Sci. J. 80: 562-569.
57. Guo, H.X. et al 2009. Long-term baicalin administration ameliorates metabolic disorders and hepatic steatosis in rats given a high-fat diet. Acta Pharmacol. Sin. 30: 1505-1512.
58. Kamisoyama, H. et al 2008. Investigation of the anti-obesity action of licorice flavonoid oil in diet-induced obese rats. Biosci. Biotechnol. Biochem. 72: 3225-3231.
59. Lee, Y.A. et al 2008. Effects of proanthocyanidin preparations on hyperlipidemia and other biomarkers in mouse model of type 2 diabetes. J. Agric. Food Chem. 56: 7781-7789.
60. Galleano, M. et al Hypertension, nitric oxide, oxidants, and dietary plant polyphenols. Curr. Pharm. Biotechnol. 11: 837-848.
61. Cassidy, A. et al 2011. Habitual intake of flavonoid subclasses and incident hypertension in adults. Am. J. Clin. Nutr. 93: 338-347.
62. Davison, K. et al 2008. Effect of cocoa flavanols and exercise on cardiometabolic risk factors in overweight and obese subjects. Int. J. Obes. 32: 1289-1296.
63. Rizza, S. et al 2011. Citrus polyphenol hesperidin stimulates production of nitric oxide in endothelial cells while improving endothelial function and reducing inflammatory markers in patients with metabolic syndrome. J. Clin. Endocrinol. Metab. 96: E782-E792.
64. Basu, A. et al 2011. Green tea minimally affects biomarkers of inflammation in obese subjects with metabolic syndrome. Nutrition 27: 206-213.
65. Tsai, H.Y. et al 2008. Effect of a proanthocyanidin-rich extract from longan flower on markers of metabolic syndrome in fructose-fed rats. J. Agric. Food Chem. 56: 11018-11024.
66. Ihm, S.H. et al 2009. Catechin prevents endothelial dysfunction in the prediabetic stage of OLETF rats by reducing vascular NADPH oxidase activity and expression. Atherosclerosis 206: 47-53.
67. Vazquez-Prieto, M.A. et al 2010. Dealcoholized red wine reverse vascular remodeling in an experimental model of metabolic syndrome: role of NAD(P)H oxidase and eNOS activity. Food Funct. 1: 124-129.
68. Agouni, A. et al 2009. Red wine polyphenols prevent metabolic and cardiovascular alterations associated with obesity in Zucker fatty rats (Fa/Fa). PLoS One 4: e5557.
69. Banini, A.E. et al 2006. Muscadine grape products intake, diet and blood constituents of non-diabetic and type 2 diabetic subjects. Nutrition 22: 1137-1145.
70. Shrime, M.G. et al 2011. Flavonoid-rich cocoa consumption affects multiple cardiovascular risk factors in a meta-analysis of short-term studies. J. Nutr. 141: 1982-1988.
71. Song, Y. et al 2005. Associations of dietary flavonoids with risk of type 2 diabetes, and markers of insulin resistance and systemic inflammation in women: a prospective study and cross-sectional analysis. J. Am. Coll. Nutr. 24: 376-384.
72. Kataja-Tuomola, M.K. et al Intake of antioxidants and risk of type 2 diabetes in a cohort of male smokers. Eur. J. Clin. Nutr. 65: 590-597.
73. Sivakumar, A.S. & C.V. Anuradha 2011. Effect of galangin supplementation on oxidative damage and inflammatory changes in fructose-fed rat liver. Chem. Biol. Interact. 193: 141-148.
74. Cao, H. et al 2007. Green tea polyphenol extract regulates the expression of genes involved in glucose uptake and insulin signaling in rats fed a high fructose diet. J. Agric. Food Chem. 55: 6372-6378.
75. Qin, B. et al 2010. Green tea polyphenols improve cardiac muscle mRNA and protein levels of signal pathways related to insulin and lipid metabolism and inflammation in insulin-resistant rats. Mol. Nutr. Food Res. 54: S14-S23.
76. Meeprom, A. et al 2011. Grape seed extract supplementation prevents high-fructose diet-induced insulin resistance in rats by improving insulin and adiponectin signalling pathways. Br. J. Nutr. 106: 1173-1181.
77. Tzeng, Y.M. et al 2009. Kaempferitrin activates the insulin signaling pathway and stimulates secretion of adiponectin in 3T3-L1 adipocytes. Eur. J. Pharmacol. 607: 27-34.